| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |